Relationship between the extent of non-viable myocardium and regional left ventricular function in chronic ischemic heart disease

Journal of Cardiovascular Magnetic Resonance

Volumn 7, Issue 3, 2005, Pages 573-579

  Kolipaka, Arunark ^a,b   Chatzimavroudis, George P ^a,b   White, Richard D ^a   Lieber, Michael L ^a   Setser, Randolph M ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cleveland State University   (United States)

Author keywords

Circumferential strain; Delayed enhancement MRI; HARP; Ischemic heart disease; Left ventricular function; Wall thickening

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; APPARATUS; ARTICLE; CALCULATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCAR; SYSTOLE;

CARDIAC OUTPUT; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20044387043     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1081/JCMR-200060652     Document Type: Article

References (25)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998; 97:282-289.
2. Stewart S, MacIntyre K, Capewell S, McMurray JJV. Heart failure and the aging population: an increasing burden in the 21st century? Heart 2003; 89:49-53.
3. Schvartzmann PR, White RD. Magnetic resonance imaging. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. 2nd ed. 2002. Philadelphia: Lippincott Williams and Wilkins, 1213-1256.
4. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Edwin W, Burdy JM, Paul Finn J, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223.
5. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36:1985-1991.
6. Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG, Hutchins GM, Kallman CA, Weisfeldt ML. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981; 63:739-746.
7. Mahrholdt H, Wagner A, Parker M, Regenfus M, Fieno DS, Bonow RO, Kim RJ, Judd RM. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 2003; 42:505-512.
8. Götte MJW, van Rossum AC, Twisk JWR, Kuijer JPA, Marcus T, Visser CA. Quantification of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol 2001; 37:808-817.
9. Kellman P, Arai AE, McVeigh ER, Haletras A. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium delayed hyperenhancement. Magn Reson Med 2002; 47:372-383.
10. Setser RM, Bexell DG, O'Donnell TP, Stillman AE, Lieber ML, Schoenhagen P, White RD. Quantitative assessment of myocardial scar in delayed-enhancement magnetic resonance imaging. J Magn Reson Imaging 2003; 18:434-441.
11. Schiller NB, Shah PM, Crawford M. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
12. van Rugge FP, van der Wall EE, Spanjersberg SJ, Albert de Ross, Matheijssen NAA, Zwinderman AH, van Dijkman PRM, Reiber JHC, Bruschke AVG. Coronary heart disease/myocardial infarction: magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease: quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90:127-138.
13. Osman NF, Kerwin WAS, McVeigh ER, Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med 1999; 42:1048-1060.
14. Glantz SA. Primer of Biostatistics. 5th ed. New York: McGraw-Hill, 2002.
15. Crowder MJ, Hand DJ. Analysis of Repeated Measures. London: Chapman & Hall, 1990.
16. Srichai MB, Schvartzman PR, Sturm B, Kasper JM, Lieber ML, White RD. Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease. Am Heart J 2004; 148:342-348.
17. Sehgal M, Hirose K, Reed JE, Rumberger JA. Regional left ventricular wall thickness and systolic function during the first year after index anterior wall myocardial infarction: serial effects of ventricular remodeling. Int J Cardiol 1996; 53:45-54.
18. Fisher MR, von Schulthess GK, Higgins CB. Multiphasic magnetic resonance imaging: normal regional left ventricular wall thickening. AJR 1985; 145:27-30.
19. Sechtem U, Sommerhoff BA, Markiewicz W, White RD, Cheitlin MD, Higgins CB. Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. Am J Cardiol 1987; 59:145-151.
20. Peshock RM, Rokey R, Malloy CM, McNamee P, Maximilian Buja L, Parkey RW, Willerson JT. Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. J Am Coll Cardiol 1989; 14:653-659.
21. Frielingsdorf J, Franke A, Kuhl HP, Rijcken E, Krebs W, Hess OM, Flachskampf FA, Hanrath P. Evaluation of regional systolic function in hypertrophic cardiomyopathy and hypertensive heart disease: a three-dimensional echocardiography study. J Am Soc Echocardiogr 1998; 11:778-786.
22. Sechtem U, Sommerhoff BA, Markiewicz W, White RD, Cheitlin MD, Higgins CB. Regional left ventricular wall thickening by magnetic resonance imaging: evaluation in normal persons and patients with global and regional dysfunction. Am J Cardiol 1987; 59:145-151.
23. 201TI in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992; 86:1125-1137.
24. 18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91:1006-1015.
25. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schisha H, Erdmann E. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31:1040-1048.